<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ibanez-Prada ED</submitter><funding>Universidad de La Sabana</funding><funding>Universidad de La Sabana (University of La Sabana)</funding><funding>MSD Colombia</funding><pagination>e0171423</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11237484</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(6)</volume><pubmed_abstract>In this study, the genetic differences and clinical impact of the carbapenemase-encoding genes among the community and healthcare-acquired infections were assessed. This retrospective, multicenter cohort study was conducted in Colombia and included patients infected with carbapenem-resistant Gram-negative rods between 2017 and 2021. Carbapenem resistance was identified by Vitek, and carbapenemase-encoding genes were identified by whole-genome sequencing (WGS) to classify the alleles and sequence types (STs). Descriptive statistics were used to determine the association of any pathogen or gene with clinical outcomes. A total of 248 patients were included, of which only 0.8% (2/248) had community-acquired infections. Regarding the identified bacteria, the most prevalent pathogens were &lt;i>Pse</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.</pubmed_title><pmcid>PMC11237484</pmcid><funding_grant_id>001</funding_grant_id><funding_grant_id>MED-315-2021</funding_grant_id><pubmed_authors>Fuentes YV</pubmed_authors><pubmed_authors>Wyres KL</pubmed_authors><pubmed_authors>Serrano-Mayorga CC</pubmed_authors><pubmed_authors>Medina S</pubmed_authors><pubmed_authors>Stewardson AJ</pubmed_authors><pubmed_authors>Reyes LF</pubmed_authors><pubmed_authors>Gamboa-Silva E</pubmed_authors><pubmed_authors>Judd LM</pubmed_authors><pubmed_authors>Josa DF</pubmed_authors><pubmed_authors>Ibanez-Prada ED</pubmed_authors><pubmed_authors>Harshegyi T</pubmed_authors><pubmed_authors>Urrego-Reyes J</pubmed_authors><pubmed_authors>Mendez L</pubmed_authors><pubmed_authors>Baron O</pubmed_authors><pubmed_authors>Africano HF</pubmed_authors><pubmed_authors>Bustos IG</pubmed_authors><pubmed_authors>Leal R</pubmed_authors><pubmed_authors>Ruiz-Cuartas A</pubmed_authors><pubmed_authors>Silva E</pubmed_authors><pubmed_authors>Beltran CC</pubmed_authors><pubmed_authors>Hawkey J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.</name><description>In this study, the genetic differences and clinical impact of the carbapenemase-encoding genes among the community and healthcare-acquired infections were assessed. This retrospective, multicenter cohort study was conducted in Colombia and included patients infected with carbapenem-resistant Gram-negative rods between 2017 and 2021. Carbapenem resistance was identified by Vitek, and carbapenemase-encoding genes were identified by whole-genome sequencing (WGS) to classify the alleles and sequence types (STs). Descriptive statistics were used to determine the association of any pathogen or gene with clinical outcomes. A total of 248 patients were included, of which only 0.8% (2/248) had community-acquired infections. Regarding the identified bacteria, the most prevalent pathogens were &lt;i>Pse</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-04T03:24:42.845Z</modification><creation>2025-04-04T03:24:42.845Z</creation></dates><accession>S-EPMC11237484</accession><cross_references><pubmed>38629835</pubmed><doi>10.1128/spectrum.01714-23</doi></cross_references></HashMap>